Limei Poon
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 10%
- Viral-associated cancers and disorders
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lymphoma Diagnosis and Treatment 11
- Oncology 9
- Viral-associated cancers and disorders 4
- CAR-T cell therapy research 2
- Co-authors
- Pek‐Lan Khong (1 shared paper)Daryl Tan (2 shared papers)Colin Phipps (1 shared paper)Thomas S. Y. Chan (1 shared paper)Seok Jin Kim (1 shared paper)Jabed Iqbal (1 shared paper)Yok‐Lam Kwong (1 shared paper)Florence Loong (1 shared paper)
- Journals
- Bone Marrow Transplantation (3 papers)Blood (2 papers)British Journal of Haematology (1 paper)Hematological Oncology (1 paper)CHEST Journal (1 paper)
- Partner nations
- SingaporeUnited StatesChina
In The Last Decade
Limei Poon
22 papers receiving 572 citations
Limei Poon's Hit Papers
Peers
Comparison fields: 5 of 38
- Pathology and Forensic Medicine 311
- Oncology 322
- Immunology 215
- Hematology 92
- Genetics 52
Countries citing papers authored by Limei Poon
This map shows the geographic impact of Limei Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Poon more than expected).
Fields of papers citing papers by Limei Poon
This network shows the impact of papers produced by Limei Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Poon. The network helps show where Limei Poon may publish in the future.
Co-authors
The 25 scholars most cited alongside Limei Poon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase Hit paper breakdown → | 2017 | 368 |
| 2 | 2024 | 34 | |
| 3 | 2012 | 34 | |
| 4 | Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. | 2013 | 29 |
| 5 | 2020 | 28 | |
| 6 | 2008 | 20 | |
| 7 | 2015 | 18 | |
| 8 | 2017 | 13 | |
| 9 | 2023 | 5 | |
| 10 | 2024 | 5 | |
| 11 | 2020 | 5 | |
| 12 | Occult respiratory viral infections in coronial autopsies: a pilot project. | 2009 | 5 |
| 13 | 2021 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2015 | 2 | |
| 16 | 2007 | 2 | |
| 17 | 2015 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2013 | 1 |
About Limei Poon
Limei Poon is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Neurology and Hematology, having authored 23 papers that have together received 580 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), CNS Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Viral-associated cancers and disorders (4 papers), Hematopoietic Stem Cell Transplantation (2 papers), T-cell and Retrovirus Studies (2 papers), CAR-T cell therapy research (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (311 citations), Oncology (322 citations), Immunology (215 citations), Hematology (92 citations) and Genetics (52 citations). Limei Poon has collaborated with scholars based in Singapore, United States and China. Frequent co-authors include Pek‐Lan Khong, Daryl Tan, Colin Phipps, Thomas S. Y. Chan, Seok Jin Kim, Jabed Iqbal, Yok‐Lam Kwong, Florence Loong, Rex Au-Yeung and Eric Tse. Their work appears in journals such as Bone Marrow Transplantation, Blood, British Journal of Haematology, Hematological Oncology and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.